The cytotoxicity of pertussis toxin, a multisubunit exotoxin produced byBordeteUapertussis, is believed to be due to the ADP-ribosyltransferase activity of the Si subunit. We have previously described the recombinant expression of each of the five individual pertussis toxin subunits in Escherichia coli and the production of an enzymaticaily deficient form of the Si subunit by site-directed mutagenesis. We now
report the in vitro assembly of holotoxin from native pertussis toxin B oligomer and recombinant Si subunits, the latter purified and refolded from insoluble inclusion bodies. Holotoxin assembled with recombinant S1 of authentic amino acid sequence was indistinguishable from native pertussis toxin in its electrophoretic migration and ability to elicit a cytopathic response in cultured Chinese hamster ovary cells; in contrast, holotoxin assembled with the genetically deactivated analog of recombinant Si displayed greatly diminished cytopathicity.
These results verify that the in vitro cytopathic effects of pertussis toxin are the result of the enzymatic activity of the S1 subunit and illustrate the potential for constructing complex quaternary protein structures in vitro from insoluble, unfolded polypeptides derived from expression in recombinant systems.
In an effort to create a fully efficacious yet less reactogenic pertussis vaccine, we have focused on the recombinant production of PTX subunit proteins, detoxification of the Si moiety by site-specific mutagenic inactivation of enzyme activity, and the in vitro assembly of a genetic "holotoxoid." For these purposes, the individual subunit polypeptides were expressed at high levels in Escherichia coli (36) , and a region of the recombinant Si subunit (Val8-Pro'5) was identified as both necessary for enzyme activity and critical for the formation of its neutralizing, protective epitope (37) . Selective site-directed mutagenesis of the subcloned S1 cistronic element permitted us to derive and analog polypeptide (Arg9 -k Lys) retaining the protective epitope, but with strikingly reduced ADP-ribosyltransferase activity (38) . We wished to assess the biological activity of this genetically deactivated S1 mutant subunit and evaluate its potential to participate in the production of a recombinant holotoxoid. To this end, we have assembled holotoxin molecules in vitro that are composed of native PTX B oligomer and recombinant SI subunits of either native or mutant sequence and evaluated their relative abilities to elicit cytotoxic responses in cultured cells.
Pertussis toxin (PTX) is both a major virulence factor of Bordetella pertussis (1), the etiologic agent of whooping cough (2) , and an important antigenic element in vaccines for immunoprotection against disease (3) (4) (5) (6) (7) . Certain clinical manifestations of infection (1, 8, 9) and minor reactions to vaccination (10, 11) are attributable to the effects of this complex exotoxin. The origin of the extremely rare adverse neurologic events temporally related to pertussis immunization remains controversial (11) (12) (13) (14) (15) . Chemical or heat treatment ("toxoiding") of whole-cell and acellular pertussis vaccines does not necessarily abolish the ability of the PTX to "reactivate" to a toxic form (16) , a phenomenon longrecognized with diphtheria toxin (17) .
PTX is hexameric, composed of five distinct proteins: S1, S2, S3, S4 (2 mol/mol of PTX), and S5 (18) . The S1 subunit, or A promoter, is an ADP-ribosyltransferase (19) that can impair signal transduction in target cell membranes (9, (19) (20) (21) (22) (23) (24) (25) . The B oligomer is composed of subunit S5 and dimers of S2-S4 and S3-S4 (18, 25, 26) . This complex, which is readily dissociable from the A protomer, is thought to provide cell receptor recognition and transport functions necessary for PTX toxicity (18, 27, 28) ; B oligomer also appears to mediate the mitogenic effects of PTX on T lymphocytes by interaction with CD3 (29) . The A and B components each possess antigenic determinants that elicit toxin-neutralizing immune responses (25, (30) (31) (32) (33) . Evidence suggests that a single neutralizing antigenic determinant on the S1 subunit may be the dominant protective epitope of PTX (32, 34, 35) .
MATERIALS AND METHODS
PTX and Purification of Recombinant S1 Subunits. Lyophilized commerical grade PTX and S1 were purchased from List Biological Laboratories (Campbell, CA), and each was dissolved in 2 M urea/25 mM sodium phosphate, pH 7.0. B oligomer was prepared from native PTX as described (25, 27) . Recombinant S1 of native sequence (rS1/1) and the recombinant analog form with the Arg9 --Lys substitution (rSl/ 1-4) were purified from E. coli by the following procedure. Bacterial cells were lysed in a French pressure cell at 10,000 psig (pounds per square inch, gauge; 1 psi = 6.89 kPa) and the insoluble inclusion body pellets were collected by centrifugation at 10,000 x g for 60 min. The pellets were solubilized in 8 M urea/25 mM Tris-HCI, pH 8.5, for 1 hr. Cupric sulfate was added to a final concentration of 50 LM, and the mixtures were stirred overnight at room temperature. These solutions were then diluted with 8 M urea/25 mM sodium citrate, pH 3.8, clarified by centrifugation, and loaded onto columns of S Sepharose FF (Pharmacia). The columns were eluted with 8 M urea/50 mM potassium phosphate, pH 7.5, and the eluant fractions were analyzed for S1 subunit by NaDodSO4/ PAGE. Fractions containing S1 were pooled, concentrated on Amicon YM-10 membranes (10,000 Mr cut-off), and fractionated on columns of Sephacryl S-200 SF (Pharmacia) equilibrated in 2 M urea/10 mM sodium phosphate, pH 7.5/200 mM NaCl.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. protein) in reaction mixtures of 200 ,ul containing 2 M urea and 25 mM sodium phosphate (pH 7.0) and incubated for 1 hr at room temperature. Samples of 150 ,ul were mixed with 30 /tl of a solution containing 50% glycerol and 0.02% methyl green and loaded onto cylindrical polyacrylamide gels. Nondenaturing, nonreducing gel electrophoresis (7.5% acrylamide, pH 4.5) was performed according to the method of Gabriel (39) . Following electrophoresis for 210 min at 200 V, gels were stained with Coomassie brilliant blue R-250.
Assessment of Chinese Hamster Ovary (CHO) Cell Cytotoxicity. Native PTX, holotoxin species from in vitro association of recombinant S1 subunit proteins (rS1/1 and rS1/1-4) with native B oligomer, and the individual components were prepared as described above. Samples ranging in starting concentrations from 30 to 50 ,g/ml were serially diluted in Ham's F-12 medium containing antibiotics and 10% fetal bovine serum, each dilution mixed with -7.5 x 103 freshly trypsinized CHO cells (ATCC CCL 61), and plated in 96-well culture dishes (27) . After incubation for 48 hr at 37TC in 5% CO2 in air to permit maximal clustering, cells were stained with crystal violet and photographed.
A B C D E F G RESULTS Enzymatically active recombinant S1 subunit (rS1/1) (36) and the deactivated analog S1 subunit (rS1/1-4), containing only an Arg9 -> Lys substitution with the otherwise native sequence (38) , were recovered from E. coli inclusion bodies and purified as described in Materials and Methods. Each form of recombinant S1, as well as S1 subunit from PTX, was individually allowed to associate with purified native B oligomer under the conditions originally described by Tamura et al. (18) . The reaction mixtures and appropriate control samples were then assessed for the presence of holotoxin by two methods: electrophoresis in nondenaturing, nonreducing polyacrylamide gels and biological activity in cultured CHO cells. Electrophoresis (Fig. 1) revealed the presence of a major band in samples composed of the native B oligomer and each of the S1 protein samples; this band comigrated with authentic B. pertussis holotoxin. When extracted and subjected to NaDodSO4/PAGE, these major bands were observed to contain all of the toxin subunits in proportions identical to those of the B. pertussis toxin standard (data not shown). These results suggest that oxidized recombinant S1 subunits, whether of native amino acid sequence or of the Arg9'-* Lys form, will associate with the B oligomer to generate stable holotoxin species. Quantitative densitometric scanning of stained gels (not shown) indicates that, even under nonoptimized conditions, association of each S1 species with B oligomer is an efficient process (>80%).
PTX induces a morphologic "clustering" of CHO cells (40) related to the membrane effects of S1 ADP-ribosyltransferase (27) , permitting in vitro biologic measurement of toxin activity. Fig. 2 illustrates the native holotoxin ( Fig. 2D ) and the holotoxin formed in these experiments with enzymatically active rS1/1 (Fig. 2F ) each evoked the clustered morphological response in CHO cells. No cytopathic effect was discernible with holotoxin containing the deactivated analog rSl/1-4 ( Fig. 2H ) at comparable concentrations. The three S1 subunit species and the B oligomer by themselves induced no biological response.
A quantitative comparison of CHO cell clustering activities for the native and recombinant holotoxins is shown in Table  1 . Similar clustering activities were observed for native holotoxin and for holotoxin prepared by association of either native S1 subunit or rS1/1 protein with purified B oligomer. In contrast, the clustering activity of hofotoxin formed from the enzymatically deficient rSl/1-4 analog (38) was 4l% of that of holotoxin containing rS1/1 (130 ng/ml versus 1.4 ng/ml). The low level of CHO cell clustering activity exhibited by the analog-containing holotoxin is consistent with thediminished ADP-ribosyltransferase activity of rS1/1-4, which is -0.1% of the native enzyme activity (38) . The lack of an exact quantitative correlation between the clustering and enzymatic activities is not unexpected. Slight contamination of the B oligomer preparations with residual PTX made precise endpoint determinations of CHO cell clustering somewhat difficult to ascertain. Moreover, although the enzyme activity is measured as the rate of ADP-ribosylation of a target protein under defined, saturating conditions, CHO cell activity is presumably the result of the cumulative (and possibly amplified) activity of the enzyme on target protein in the cell membrane. High concentrations of a less active enzyme, given adequate time, may be capable of modifying sufficient substrate to induce clustering.
DISCUSSION
Multisubunit bacterial exotoxins, including PTX and cholera toxin, are currently being examined for their potential as vaccines (5) (6) (7) 41) . Coincidently, they may serve as models for the study of assembly pathways for oligomeric proteins (42) . Previous reports have established that PTX (18) and cholera toxin (42) can be dissociated into individual subunits and subsequently reassembled in vitro to form biologically active holotoxin macromolecules. The goal of our work has been to prepare a candidate pertussis vaccine by the in vitro assembly of individual recombinant PTX subunits obtained from inclusion bodies of E. coli. Unlike the specific assembly of holotoxin from native materials, the use of inclusion body-derived subunits requires the solubilization and appropriate oxidation of disulfide bonds for each of the various subunits as a prerequisite for oligomerization (42) . As a preliminary step toward the in vitro assembly of pertussis 130.0 ± 29.0 CHO cell clustering assays were performed as described in the text. The concentration of complete holotoxin in each preparation was determined prior to dilution by quantitative densitometric scanning of Coomassie blue-stained polyacylamide gels run as in Fig. 1 . Residual PTX activity in this B oligomer preparation (27) , estimated at 0.6% of total protein, was observed in the CHO cell assay at a dilution of 1:400; this titer was subtracted from that of each experimental endpoint titer prior to its conversion to activity units. The calculations represent the mean ± SD of results obtained from triplicate 2-fold dilution series performed at two separate starting concentrations of each sample.
holotoxin entirely from recombinant subunits, we have assessed the ability of recombinant S1 subunit to associate with native B oligomer.
Purified recombinant S1 (rS1/1) exhibits ADP-ribosyltransferase activity identical to that of the natural S1 (43) . When combined with purified B oligomer, rS1/1 forms holotoxin that is indistinguishable from the native toxin in gel electrophoretic migration ( Fig. 1 ) and in clustering activity against CHO cells (Table 1) . Recombinant S1/1-4, which contains the single Arg9 -* Lys substitution in the otherwise native S1 sequence, is also capable of associating with B oligomer to form a holotoxin species having an identical electrophoretic migration. However, the resultant toxin displays markedly lower CHO cells clustering activity, reflecting the diminished enzymatic activity of the rSl/1-4 subunit. We anticipate that holotoxin containing this mutant subunit will also exhibit reduced in vitro toxicity when compared to the ability of native PTX to elicit lymphocytosis, hyperinsulinemia, and histamine sensitization in laboratory animals. Reduced biological activity has been reported for an enzymedeficient holotoxin secreted by recombinant B. pertussis (44) .
Recent reports suggest that the dominant protective epitope on the S1 subunit is discontinuous (32, 35, 37) , perhaps assuming its native conformation after association with the B oligomer. That recombinant S1 protein and the B oligomer combine to yield a functional holotoxin suggests that this important antigenic determinant may also be formed in this complex. Despite the single amino acid substitution in rSl/ 1-4, computer-assisted analyses (45, 46) could reveal no significant secondary structural differences between this analog and the native S1 protein that might influence conformation, holotoxin assembly, and epitope display. We have intentionally employed only S1 species with native mature amino termini (36) in order to avoid any potential interference of fusion protein sequences in the interactions that lead to holotoxin assembly.
Although confirmation to structural identity between recombinant and native holotoxins will require further physical and immunological assessment, our results indicate that authentic PTX can be formed in vitro from S1 subunits derived from recombinant inclusion bodies. In a broader sense, these investigations illustrate how assembly of oligomeric proteins from recombinant monomers may facilitate structural studies of complex macromolecules. Of more immediate interest, however, is the possibility that formation of pertussis holotoxin from an enzymatically deficient analog subunit may result in a new and safer pertussis toxoid vaccine.
